Pharma's Almanac TVPA TV
Your Name
Your Email
  • Manage Account
  • Sign Out
Sign In
Register
     
    • Follow the Journey
    • Companies On The Road
    • Arcadis DPS Group
    • C2 Pharma
    • CAI
    • EcoLab
    • Environmental Systems Corporation
    • Federal Equipment Company
    • Globyz Biopharma Services
    • Grifols
    • Integrity
    • Nu-Tek BioSciences
    • PHARMALEX
    • Waters Corporation
    • Follow the Completed Journey
    • Companies On The Road
    • Follow The Artist
    • ABS
    • aCGT Vector
    • Alconox Inc.
    • Andelyn Biosciences
    • Arranta Bio
    • Avid Bioservices
    • BDD
    • BIOVECTRA
    • DPS Group
    • Dynamk Capital
    • Environmental Systems Corporation
    • Federal Equipment Company
    • Genesis AEC
    • Globyz Biopharma Services
    • Grifols Partnership
    • IDT Biologika
    • Inceptor Bio
    • IPS-Integrated Project Services
    • Kineticos Life Sciences
    • MilliporeSigma
    • Montana BioScience Alliance
    • Olon
    • Rentschler Biopharma
    • SanaClis
    • Scorpion Biological Services
    • Secant Group
    • Tapemark
    • VITRONIC
    • Follow the Completed Journey
    • Companies We've Met
    • AES Clean Technology
    • Altis Biosystems
    • Arranta Bio
    • Avara Pharmaceutical Services
    • Avid Bioservices
    • BioVectra
    • Centaur BPS
    • Dynamk Capital
    • ECRI
    • Evolve Biologics
    • Federal Equipment Company
    • Globyz
    • Inceptor Bio
    • IPS-Integrated Project Services
    • Olon
    • Pii
    • Polpharma Biologics
    • PPD
    • RoosterBio
    • SanaClis
    • Sanofi AIS
    • SGD Pharma
    • SPI Pharma
    • TriRx Pharmaceutical Services
    • Yourway
    Dashboard
    • Topics
        Products
        • ADC
        • API - Small Molecule
        • Biologics
        • Biopharmaceuticals
        • Biosimilars
        • Cell and Gene Therapy
        • DNA
        • Drug Product
        • Drug Substance
        • Equipment
        • Generics
        • Immunotherapy
        • Injectables
        • Monoclonal Antibody
        • Novel Therapeutics
        • Oral Solid Dosage
        • Orphan Drugs
        • Parenterals
        • Stem Cells
        • Vaccine
        Services
        • Big Data
        • Bioprocessing
        • Clinical Trials
        • Continuous Manufacturing
        • Diagnostics
        • Drug Delivery
        • Drug Development
        • Drug Discovery
        • Facility
        • Formulation
        • Innovation
        • Oncology
        • Patient Adherence
        • Patient Centric
        • Preclinical
        • Process Development
        • Quality
        • Regulatory
        • Research
        • Serialization
        Segment
        • Biomanufacturing
        • Biotechnology
        • CDMO
        • Consulting
        • CRO
        • Engineering
        • Equipment
        • Excipients
        • Healthcare
        • Intermediates
        • Logistics
        • Manufacturing
        • Packaging
        • Supply Chain
        Business
        • Agreement
        • Appointment
        • Business
        • Capacity Expansion
        • Collaboration
        • Growth
        • Investment
        • Licensing
        • M&A
        • Market Expansion
        • Market Intelligence
        • Market Prediction
        • New Facility
        • Strategic Partnership
    • Magazine
      • Archive
    • Reports
      • 2021 Cell & Gene Therapy Report
      • 2021 Monoclonal Antibody & Recombinant Protein Market Report
      • 2022 Sterile Drug Market Report
      • 2022 API Market Report
      • 2022 OSD Market Report
    • Community
    • Company A to Z
    • Follow the Journey
    • Companies On The Road
    • Follow The Artist
    • Follow the Journey
    • Companies On The Road
    • More+
      • Staffing
      • Media Kit

    Advanced Therapies

    9 Articles Available

    Can't find what you're looking for? Try our advanced search.

    Biopharma Facility Design

    Growing a Global Presence with a Continued Focus on Life Sciences Facilities
    PAO-02-23-PATV-03

    Immuno-Oncology

    Building Multiple Platforms to Address Difficult-to-Treat Cancers
    PAO-05-22-R250-09

    Pharma's Almanac

    The Evolution and the Future of Pharma
    PAO-03-22-R250-07

    Cell and Gene Therapy

    Realizing the Promise of Cell and Gene Therapy with an Advanced Manufacturing Platform
    PAO-01-22-R250-15

    Cell Therapy

    Enabling Novel Cell Therapies by Leveraging Established Blood Stem Cell Transplant Infrastructure
    PAO-09-21-CL-04

    mRNA Therapies

    Realizing the Promise of RNA Therapies with Lipid Nanoparticle Delivery
    PAO-06-21-CL-08

    Cell and Gene Therapy

    Expanding a Comprehensive Platform to Support the Future of Cell and Gene Therapies
    PAO-05-21-CL-05

    COVID-19 Impacts

    Q: Putting aside COVID-19 vaccines and therapeutics, what do you think will be the most significant development in the industry in 2021?
    PAO-03-21-NI-01

    Cell and Gene Therapy

    Advanced Therapies: Landscape, the Road Forward, and M&A
    PAP-Q2-2019-CL-021

    About Us
    That’s Nice Staffing
    More
    Media Kit Download Current Issue
    Your Account
    Manage Your Account Dashboard Sign Out
    Sign In Register
    Help
    Contact Us Support
    Nice Insight/That’s Nice

    89 Fifth Avenue
    Fifth Floor
    New York
    NY 10003-3020

    New York – San Diego – Chicago
    London – Frankfurt – Shanghai

    Nice Insight is the market research division of That’s Nice LLC, the leading marketing agency serving life sciences.

    © PHARMA’S ALMANAC 2023 Terms and Conditions